CN106692137A - Mammary duct treatment method of acute mastitis - Google Patents
Mammary duct treatment method of acute mastitis Download PDFInfo
- Publication number
- CN106692137A CN106692137A CN201611223439.6A CN201611223439A CN106692137A CN 106692137 A CN106692137 A CN 106692137A CN 201611223439 A CN201611223439 A CN 201611223439A CN 106692137 A CN106692137 A CN 106692137A
- Authority
- CN
- China
- Prior art keywords
- syringe
- aseptic
- injection
- milk duct
- milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a mammary duct treatment method of acute mastitis. The mammary duct treatment method adopts a sterile silver needle, lidocaine, 0.9% sodium chloride injection, metronidazole injection, ethyl alcohol, sterile absorbent cotton, a sterile syringe needle, a first injector and a second injector. The mammary duct treatment method of acute mastitis facilitates effective dredging and discharge conducted by medical workers on milk accumulated in the breasts of an acute mastitis patient through simple operation. In addition, the suffering of the patients and discomfort in treatment can be greatly relieved through matched usage of the lidocaine and the 0.9% sodium chloride injection. Furthermore, fear, scare and other emotions of the patients are also greatly reduced, and accordingly convenience is brought to follow-up treatment of the patients.
Description
Technical field
The present invention relates to a kind of medical field, more particularly to a kind of acute mastitis milk duct treatment method.
Background technology
During treating, breast portion occurs galactostasis, but nipple position to current Clinical Acute mastitis patient
Milk cannot be excluded, and now, is such as emptied not in time, easily cause infection, after causing bacterium to invade lactiferous ducts, continue to be invaded to substantial part
Violate, so that various types of suppurative mastitis are formed, to the great danger of patient, in view of disadvantages described above, is necessary design in fact
A kind of milk duct treatment method of acute mastitis.
The content of the invention
The technical problems to be solved by the invention are：A kind of milk duct treatment method of acute mastitis is provided to solve
Certainly current acute mastitis patient, breast milk alluvial, it is impossible to exclude the problem of milk.
In order to solve the above technical problems, the technical scheme is that：A kind of milk duct treatment method of acute mastitis,
Including aseptic acupuncture needle, lidocaine, 0.9% sodium chloride injection, Metronidazule injection, alcohol, aseptic absorbent cotton, aseptic syringe needle,
First syringe, the second syringe, described aseptic acupuncture needle diameter 0.5mm, described lidocaine dose is 3ml, described
0.9% sodium chloride injection dose is 100ml, and described Metronidazule injection dose is 250ml, and described alcohol is medical wine
Essence, described aseptic absorbent cotton quantity is some, if described aseptic syringe needle quantity is 2, described aseptic syringe needle is tack
Pin, the first described syringe is 5ml, and the second described syringe is 10ml.
Its job step is as follows：
A, first by lidocaine and 0.9% sodium chloride injection 1:1 dilution turns into dilution；
B, again with the first syringe suck dilution；
C, again by the first syringe change aseptic syringe needle it is standby；
D, again with the second syringe suck Metronidazule injection；
E, again by the second syringe change aseptic syringe needle it is standby；
F, seek patient with aseptic acupuncture needle again and deposit milk duct opening；
G, operate the first syringe that dilution instils aseptic acupuncture needle surface again, aseptic acupuncture needle then goed deep into milk duct,
Local anaesthesia is carried out to patient's milk duct position by dilution, aseptic acupuncture needle is then taken out；
H, the second syringe is operated again, Metronidazule injection is injected by milk duct opening, i.e., injected by metronidazole
The impulse force that liquid injection milk duct is produced, carries out breaing up and becomes silted up to alluvial milk, then just can be taken off the second syringe；
I, with hand patient's mammary areola position is pressed again, Metronidazule injection and the alluvial milk in milk duct is together discharged.
Further, following steps are additionally provided with before the f steps：
A, aseptic absorbent cotton immersion alcohol；
B, again with immersion alcohol aseptic absorbent cotton cleaning and sterilizing is carried out to patient's nipple position.
Further, injection rate single is 3ml Metronidazule injections in the h steps.
Lidocaine：Analgesia, Central nervous system has obvious inhibitory action；
0.9% sodium chloride injection：Prevent the too low damage human body of human internal environment's osmotic pressure；
Metronidazule injection；Anti-inflammatory, is mainly used in the treatment of anaerobic infection.
Compared with prior art, the milk duct treatment method of the acute mastitis, by shirtsleeve operation, is easy to medical care people
Member carries out effective dredging discharge to acute mastitis patient alluvial in intramammary milk, additionally, by lidocaine and
Using cooperatively for 0.9% sodium chloride injection, can greatly mitigate discomfort when pain and the treatment of patient, meanwhile,
The mood such as frightened and alarmed for greatly reducing that patient occurs, so as to be offered convenience to patient's successive treatment.
Brief description of the drawings
Fig. 1 is a kind of flow chart of the milk duct treatment method of acute mastitis；
Following specific embodiment will be further illustrated with reference to above-mentioned accompanying drawing.
Specific embodiment
Hereinafter, various specific details are elaborated, to provide the saturating of the concept to constituting described embodiment basis
Thorough understanding, however, it will be apparent to those skilled in the art that described embodiment can be without these specific details
In it is some or all in the case of put into practice, in other cases, without specifically describing well-known process step.
Example 1
As shown in figure 1, a kind of milk duct treatment method of acute mastitis, including aseptic acupuncture needle, lidocaine, 0.9%
Sodium chloride injection, Metronidazule injection, alcohol, aseptic absorbent cotton, aseptic syringe needle, the first syringe, the second syringe, it is described
Aseptic acupuncture needle diameter 0.5mm, described lidocaine dose is 3ml, and 0.9% described sodium chloride injection dose is 100ml,
Described Metronidazule injection dose is 250ml, and described alcohol is medicinal alcohol, and described aseptic absorbent cotton quantity is some
Part, if described aseptic syringe needle quantity is 2, described aseptic syringe needle is tack pin, and the first described syringe is 5ml, institute
The second syringe stated is 10ml.
Its job step is as follows：
A, first by lidocaine and 0.9% sodium chloride injection 1:1 dilution turns into dilution；
B, again with the first syringe suck dilution；
C, again by the first syringe change aseptic syringe needle it is standby；
D, again with the second syringe suck Metronidazule injection；
E, again by the second syringe change aseptic syringe needle it is standby；
F, seek patient with aseptic acupuncture needle again and deposit milk duct opening；
G, operate the first syringe that dilution instils aseptic acupuncture needle surface again, aseptic acupuncture needle then goed deep into milk duct,
Local anaesthesia is carried out to patient's milk duct position by dilution, aseptic acupuncture needle is then taken out；
H, the second syringe is operated again, Metronidazule injection is injected by milk duct opening, i.e., injected by metronidazole
The impulse force that liquid injection milk duct is produced, carries out breaing up and becomes silted up to alluvial milk, then just can be taken off the second syringe；
I, with hand patient's mammary areola position is pressed again, Metronidazule injection and the alluvial milk in milk duct is together discharged.
Further, following steps are additionally provided with before the f steps：
A, aseptic absorbent cotton immersion alcohol；
B, again with immersion alcohol aseptic absorbent cotton cleaning and sterilizing is carried out to patient's nipple position.
Further, injection rate single is 3ml Metronidazule injections in the h steps.
Lidocaine：Analgesia, Central nervous system has obvious inhibitory action；
0.9% sodium chloride injection：Prevent the too low damage human body of human internal environment's osmotic pressure；
Metronidazule injection；Anti-inflammatory, is mainly used in the treatment of anaerobic infection.
The milk duct treatment method of the acute mastitis, by shirtsleeve operation, is easy to medical personnel to acute mastitis
Patient's alluvial carries out effective dredging discharge in intramammary milk, additionally, passing through lidocaine and 0.9% chloride injection
Using cooperatively for liquid, can greatly mitigate discomfort when pain and the treatment of patient, meanwhile, also greatly reduce patient and occur
The mood such as frightened and alarmed, so as to be offered convenience to patient's successive treatment.
Example 2
As shown in figure 1, a kind of milk duct treatment method of acute mastitis, including aseptic acupuncture needle, lidocaine, 0.9%
Sodium chloride injection, Metronidazule injection, alcohol, aseptic absorbent cotton, aseptic syringe needle, the first syringe, the second syringe, it is described
Aseptic acupuncture needle diameter 0.5mm, described lidocaine dose is 3ml, and 0.9% described sodium chloride injection dose is 100ml,
Described Metronidazule injection dose is 250ml, and described alcohol is medicinal alcohol, and described aseptic absorbent cotton quantity is some
Part, if described aseptic syringe needle quantity is 2, described aseptic syringe needle is tack pin, and the first described syringe is 5ml, institute
The second syringe stated is 10ml.
Its job step is as follows：
A, first by lidocaine and 0.9% sodium chloride injection 1:1 dilution turns into dilution；
B, again with the first syringe suck dilution；
C, again by the first syringe change aseptic syringe needle it is standby；
D, again with the second syringe suck Metronidazule injection；
E, again by the second syringe change aseptic syringe needle it is standby；
F, seek patient with aseptic acupuncture needle again and deposit milk duct opening；
G, operate the first syringe that dilution instils aseptic acupuncture needle surface again, aseptic acupuncture needle then goed deep into milk duct,
Local anaesthesia is carried out to patient's milk duct position by dilution, aseptic acupuncture needle is then taken out；
H, the second syringe is operated again, Metronidazule injection is injected by milk duct opening, i.e., injected by metronidazole
The impulse force that liquid injection milk duct is produced, carries out breaing up and becomes silted up to alluvial milk, then just can be taken off the second syringe；
I, with hand patient's mammary areola position is pressed again, Metronidazule injection and the alluvial milk in milk duct is together discharged.
Further, following steps are additionally provided with before the f steps：
A, aseptic absorbent cotton immersion alcohol；
B, again with immersion alcohol aseptic absorbent cotton cleaning and sterilizing is carried out to patient's nipple position.
Further, injection rate single is 1ml Metronidazule injections in the h steps.
Lidocaine：Analgesia, Central nervous system has obvious inhibitory action；
0.9% sodium chloride injection：Prevent the too low damage human body of human internal environment's osmotic pressure；
Metronidazule injection；Anti-inflammatory, is mainly used in the treatment of anaerobic infection.
The milk duct treatment method of the acute mastitis, by shirtsleeve operation, is easy to medical personnel to acute mastitis
Patient's alluvial carries out effective dredging discharge in intramammary milk, additionally, passing through lidocaine and 0.9% chloride injection
Using cooperatively for liquid, can greatly mitigate discomfort when pain and the treatment of patient, meanwhile, also greatly reduce patient and occur
The mood such as frightened and alarmed, so as to be offered convenience to patient's successive treatment.
The present invention is not limited to above-mentioned specific embodiment, one of ordinary skill in the art from above-mentioned design,
Performing creative labour is not only crossed, a variety of conversion made are within the scope of the present invention.
Claims (3)
1. the milk duct treatment method of a kind of acute mastitis, it is characterised in that including aseptic acupuncture needle, lidocaine, 0.9% chlorine
Change sodium injection, Metronidazule injection, alcohol, aseptic absorbent cotton, aseptic syringe needle, the first syringe, the second syringe, described nothing
Bacterium acupuncture needle diameter 0.5mm, described lidocaine dose is 3ml, and 0.9% described sodium chloride injection dose is 100ml, institute
The Metronidazule injection dose stated is 250ml, and described alcohol is medicinal alcohol, and described aseptic absorbent cotton quantity is some,
If described aseptic syringe needle quantity is 2, described aseptic syringe needle is tack pin, and the first described syringe is 5ml, described
Second syringe is 10ml.
Its job step is as follows：
A, first by lidocaine and 0.9% sodium chloride injection 1:1 dilution turns into dilution；
B, again with the first syringe suck dilution；
C, again by the first syringe change aseptic syringe needle it is standby；
D, again with the second syringe suck Metronidazule injection；
E, again by the second syringe change aseptic syringe needle it is standby；
F, seek patient with aseptic acupuncture needle again and deposit milk duct opening；
G, operate the first syringe that dilution instils aseptic acupuncture needle surface again, aseptic acupuncture needle is then goed deep into milk duct, that is, lead to
Cross dilution carries out local anaesthesia to patient's milk duct position, then takes out aseptic acupuncture needle；
H, the second syringe is operated again, Metronidazule injection is injected by milk duct opening, i.e., noted by Metronidazule injection
Enter the impulse force of milk duct generation, carrying out breaing up to alluvial milk becomes silted up, and then just can be taken off the second syringe；
I, with hand patient's mammary areola position is pressed again, Metronidazule injection and the alluvial milk in milk duct is together discharged.
2. the milk duct treatment method of a kind of acute mastitis as claimed in claim 1, it is characterised in that before the f steps
It is additionally provided with following steps：
A, aseptic absorbent cotton immersion alcohol；
B, again with immersion alcohol aseptic absorbent cotton cleaning and sterilizing is carried out to patient's nipple position.
3. the milk duct treatment method of a kind of acute mastitis as claimed in claim 2, it is characterised in that noted in the h steps
Enter amount single for 3ml Metronidazule injections.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611223439.6A CN106692137A (en) | 2016-12-27 | 2016-12-27 | Mammary duct treatment method of acute mastitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611223439.6A CN106692137A (en) | 2016-12-27 | 2016-12-27 | Mammary duct treatment method of acute mastitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106692137A true CN106692137A (en) | 2017-05-24 |
Family
ID=58896244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611223439.6A Pending CN106692137A (en) | 2016-12-27 | 2016-12-27 | Mammary duct treatment method of acute mastitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106692137A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066269A (en) * | 1991-05-02 | 1992-11-18 | 伊莱利利公司 | The methods of treatment of mazoitis |
| CN1850045A (en) * | 2006-05-22 | 2006-10-25 | 济南康泉医药科技有限公司 | Slow-release preparation containing macrolides anti biotics |
-
2016
- 2016-12-27 CN CN201611223439.6A patent/CN106692137A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066269A (en) * | 1991-05-02 | 1992-11-18 | 伊莱利利公司 | The methods of treatment of mazoitis |
| CN1850045A (en) * | 2006-05-22 | 2006-10-25 | 济南康泉医药科技有限公司 | Slow-release preparation containing macrolides anti biotics |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203749919U (en) | Needleless infusion device | |
| CN207341978U (en) | A kind of intestinal tract rinsing bag for being easy to elements addition medicine in therapeutic process | |
| CN106692137A (en) | Mammary duct treatment method of acute mastitis | |
| CN203342098U (en) | Negative pressure drainage device | |
| CN209378147U (en) | A kind of irrigation of bladder device | |
| CN208049111U (en) | Disposable convenient infusion apparatus | |
| CN203425302U (en) | Saccule enemator | |
| CN201366130Y (en) | Novel infusing device | |
| CN101927041A (en) | Transfusion apparatus capable of stopping liquid automatically and preventing blood return | |
| CN211658849U (en) | Clinical drainage device that uses of department of general surgery | |
| CN206214508U (en) | One kind improvement Three-way transfusion system | |
| CN204910350U (en) | Ware of dosing is fixed a position to anus intestines | |
| CN205055022U (en) | Transfusion apparatus | |
| CN204671557U (en) | A kind of can the cross infection preventing infusion bottle of ventilation at the bottom of bottle | |
| CN213823127U (en) | Injection device for anorectal administration | |
| CN212699067U (en) | Minimally invasive intervention type drug delivery device | |
| CN201414966Y (en) | Automatic solution stopping and blood-return preventing transfusion device | |
| CN213252048U (en) | Medicine-saving dropper bottle plug puncture device | |
| CN210844706U (en) | Chinese and western combined traditional Chinese medicine injection device | |
| CN210904364U (en) | Novel negative pressure transfusion device | |
| CN202961354U (en) | Pressurizing injector for medical nursing | |
| CN208405375U (en) | A kind of department of anesthesia of hospital drug metering regulating device | |
| CN202538048U (en) | Multifunctional intravenous infusion set | |
| CN205598346U (en) | Disposable intravenous infusion needle | |
| CN201744001U (en) | Intravenous injector connector |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170524 |